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Part A 
Synthesis of Azure-B Neuropeptide Conjugates 
CHAPTER I 
STATEMENT OF THE PROBLEM 
The objective of our project was to attach a dye molecule to specific peptides. 
When this dye part is excited photochemically to a triplet state, it can transfer energy to 
oxygen to form excited singlet oxygen. The singlet oxygen thus formed in situ is highly 
reactive and can react with C-H, S-H etc. When the dye is attached to a peptide, the peptide 
can bind to a specific receptor site on a cell. Once the binding takes place, excitation of the 
dye part can lead to formation of singlet oxygen molecules at the cell surface. These singlet 
oxygen molecules being very reactive, can react with and destroy the cancerous cell. The 
receptor site to which the peptide part binds, is a function of the kind of peptide used. Thus 
by using the right peptide, the dye molecule can be carried to the desired tissue in the body. 
cl 
+ 
+ H3NCH:zCH:zCI 
~ 
~ ~M K-1ert-bu10;,de 
11.3c~ S N(CHy2 
+ 
c1· 
.4 
... 
The dye will be modified in four steps. Di- tert-butyl dicarbonate (1) will be 
reacted with 2-chloroethylamine W to form N-tert-butoxycarbonyl-2-chloroethylamine 
(l). It will be coupled with the zwitterion of Azure-B (!) and converted to 
N-(2-aminoethyl)Azure-B (SJ by heating in the appropriate solvent. N-(2-
2 
3 
aminoethyl)Azure-B will be converted to N-(2-chloroacetyl amidoethyl)Azure-B (fil by 
reacting with chloroacetyl chloride. N-(2-Chloroacetyl amidoethyl)Azure-B will be 
coupled with different peptides in dilute acetic acid. 
The conjugates will be characterized by UV, HPLC and 1H-NMR. 
CHAPTER II 
INTRODUCTION 
There are several diseases that take place at receptor levels such as cardiac, 
neurological or psychiatric disorders. Very high receptor concentrations were found in 
striatal tissue in Parkinsonism, 1,2 tardive dyskinesia3 and schizophrenia.1,3 Drugs that are 
currently used have several limitations. 4 They are not very specific and hence affect other 
receptors, thus blocking important functions. The side effects can be more dangerous than 
the disease itself. The other problems are drug tolerance and overdosing. 
It was reported by Raab5 that acridine dye is toxic to paramecia only when exposed 
to light. Meyer-Betz6 reported a development of cutaneous edema upon injection of 
hematoporphyrin, followed by exposure to sunlight. These observations led to 
development of the very important technique of photodynamic therapy. 
Miller and Selverston 7 were the first to find that single cells could be killed within a 
tissue without affecting other cells. It was done by filling a single cell with photoabsorptive 
dye and irradiating the tissue with high-intensity light. They used fluorescent light which 
has some limitations. It does not penetrate soft tissues and it can damage the cells by itself. 
Anderson and Parrish8-11 studied absorptive properties of human skin, soft tissue, 
and microvasculature and found that different laser wavelengths could be used to cause 
specific damage to pigmented tissue. A very brief pulse of laser energy was used. A cell 
filled with a dye absorbs more laser energy than the surrounding tissue and warms up. It 
causes the cell temperature to exceed the protein denaturation temperature and thus destroys 
the cell. After a short period, thermal equilibrium takes place and the whole tissue starts 
warming up slowly. Hence it is essential that duration of laser exposure should not exceed 
thermal relaxation of the tissue. They also found that nanosecond laser pulses were 
necessary to selectively destroy cells without affecting tissue. Higher energy pulses were 
4 
5 
used to destroy microvessels and melanosomes several millimeters beneath the stain 
surface. 
For some photosensitizers, the production of singlet oxygen is the mechanism by 
which the cells are destroyed within a tissue.12 The cell is filled with a specific 
photosensitizer and irradiated with a laser beam. The photosensitizer forms singlet oxygen 
within the cell. Singlet oxygen is very toxic to the cell and can diffuse up to 0.1-0.2 µ, so 
the technique is highly selective. On the other hand, sometimes cytotoxic agents cause 
undesirable damage to neighboring cells. 
Selection of the chromophore is very important.13 Most fluroscent dyes require 
light-wavelengths less than 500 nm which do not penetrate mammalian tissue efficiently. 
For selective destruction of tissue, a laser of high penetration power is required. Generally 
the laser wavelength used for these purposes is 650-850 nm. It is necessary to have a 
chromophore that absorbs in this range. Lasers in this range can penetrate unpigmented 
tissue up to several millimeters without causing any damage. 
Polycyclic aromatic hydrocarbons such as pyrenes and organic dyes (methylene 
blue or Acridine orange) act as photosensitizers.14 They catalyze conversion of ground 
state triplet 3o2 to extremely reactive singlet oxygen lo2. The photosensitizer molecule 
first reaches the effective site where it generates singlet oxygen. The lifetime of singlet 
oxygen is very short. Once singlet oxygen is generated, it decays to the ground state or 
reacts with a substrate. To cause damage to that cell, it does not have to penetrate inside the 
cell. It is capable of modifying any component of the biological system. In this respect, its 
binding to different cell components is not always necessary. It can react with lipids, 
proteins and nucleic acids. Site of reaction of a photosensitizer depends upon its 
intracellular location. If the photosensitizer can bind tightly to DNA, followed by breakage 
of DNA strands, it can cause genetic damage. If a photosensitizer is soluble in fat, it will 
cause membrane damage. It can alter the structures of mitochondria and endoplasmic 
6 
reticulum. It appears that this technique can destroy cells by different mechanisms. In 
some cases it was found that concentration of a photosensitizer in specific cell parts was 
critical for cell destruction.14 In contrast, a photosensitizer bound to polystyrene beads and 
hence restricted to extracellular space, can inactivate some specific bacteria, but the same 
photosensitizer was ineffective when injected in solution form. 
Photodynamic therapy is selective in different aspecrs.15 
1. Application - It can be applied to a small group of cells or a single cell using specific 
carrier molecules. 
2. Uptake - The affinity of different cells for the carrier is different. Hence, specific 
cells such as tumor cells can bind to the canier molecule more readily than the normal 
cells. This cell property provides a selectivity for destroying only the tumor cells. 
3. Illumination - The modem technology of fiber optics can be used to illuminate specific 
portions of tissue. Using this technology, it is also possible to irradiate only part of a 
single cell. 
4. Susceptibility - The light will not affect any of the cell processes for normal cells. 
There are different techniques to destroy specific cells.14 
1. Photosensitizers can be directed towards a particular site. 
2. A prodrug can be used that breaks down to release a drug in high concentrations. 
3. A drug can be released from a carrier using light. Liposomes can be used as carriers of 
photosensitirers. 
7 
Photoaffinity reagent Photoisomerizable lipid 
Photosensitive chelator Photoactivable prodrug 
The technique of photodynamic therapy appears to be very useful. Several types 
of carrier systems have been used in the past, including antibodies and liposomes. 
Devising a proper system to carry a photosensitizer to the receptor site in specific 
application is an important achievement in the medical field. A specific and selective 
delivery of the drugs to the specific cells within the normal tissue will be clinically very 
useful. 
In one report, human T cells were used to test the idea of transporting drugs using 
monoclonal antibodies.14 They selectively destroyed human T cells without affecting the 
B cells. Liposomes were prepared containing pyrene. Pyrene was then attached to a lipid 
bilayer. A monoclonal antibody was attached to these liposome surfaces. This antibody 
was bound to 90% T cells in human blood lymphocytes. Liposomes can carry both 
hydrophilic and hydrophobic molecules trapped in the intravescular space. They were then 
irradiated with UV light when most of the T cells were destroyed and the B cells stayed 
untouched. 
8 
Hematoporphyrin derivatives are widely used for cancer therapy for lung, bladder 
and skin tumors.14 Patients are given hematoporphyrin derivatives several days before the 
optical therapy is used. Tumors are irradiated with laser beam through fiber optics. The 
recovery rate is 70-80% for early stages. However, a major limitation of this technique is 
that it cannot be used in vicinity of liver, spleen or kidneys. There are reports of using 
hematoporphyrin labeled antibodies to destroy myosarcoma or leukemia.14 
Selective cell destruction can be carried out both in vitro and in vivo technique. In 
the case of in vitro studies,16, 17 short laser pulses in 650-700 nm range were effective. 
The damage was done either by thermal or singlet oxygen mechanisms. The important 
factors were dye concentration within the cell and the dose of laser irradiation. It was 
necessary to use a carrier system to carry the dye molecule to the desired tissue. Several 
different systems were studied without significant success. Different lectins were used for 
dye conjugation. However, it was not useful for in vivo18use. Liposomes with high dye 
concentration were successful for in vitro studies but three dimensional diffusion limited in 
vivo studies. One interesting technique reported was the use of polymer beads as a 
carrier.19 These beads have a diameter of a few nanometers and they can hold a high 
concentration of a chromophore. These beads are made from a special type of polymer 
which is biocompatible and resistent to degradation. Important factors in this technique are 
particle size, particle surface charge and number of particles at the injection site. One 
carrier system reported is latex particles. These particles can be loaded with up to 14% 
(wt/wt) of a dye. This binding did not change the efficiency of singlet oxygen production. 
In one study chlorin e6 was incorporated into latex particles.12 It was found that latex 
particles do not diffuse at the injection site or form the labelled cells. The cells were labeled 
in vitro and then transplanted in vivo. Other techniques used earlier were not capable of 
carrying high concentrations of the photosensitizer. 
9 
We are developing a new technique that involves a peptide covalently bound to a 
dye. The peptide will carry the dye to a specific receptor site. After the receptor binding 
takes place, the dye will be irradiated with laser. This will lead to a formation of singlet 
oxygen which will inactivate the neighboring receptors. The important aspects of this 
technique are: (1) It should have a high quantum yield of singlet oxygen. (2) To have 
enough concentration of 102 at the receptor site, it should not diffuse more than 100 A. 
(3) The dye-peptide conjugate must have the same affinity for the receptor site as the 
peptide. 
This technique provides a new tool to cure several diseases of the receptor level. 
There are several advantages of this technique. Only a narrow area around the intended 
receptor will be affected. The effect will last much longer than the drugs commonly used. 
Several side effects caused by regular drugs such as overdosing, drug abuse and drug 
tolerance problems can be eliminated. 
This technique also has several other advantages. It will be possible to study 
different conjugates coupled to specific receptors and their response in those regions. 
Thus, based on a specific peptide used, it may be possible to cure the disorders in those 
particular receptor sites. When this technique is fully developed, it will have advantages in 
different medical fields such as neurosurgery, neurogenic and musculoskeletal disorders, 
movement disorders, neuropsychiatric disorders such as schizophrenia. 
We are using an analogue of a neuropeptide called FMRF-amide. It was first 
detected by Price and Greenburg20 in Lamellibranch Macrocallirta. It was also found. in 
several different species such as Mollusca, Insecta, Crustaca and Mammalia.21-23 Payza 
and coworkers24 reported electrophysiological characterization of effects of FMRF-amide. 
They also showed its function as a neurotransmitter in Helix brain. It was also found in 
Helix/auricle and AV junction. 25 Its function in different activities such as 
cardioexcitatory26, regulation of feeding27 and muscle contractibility28 has been reported. 
10 
For our work, analogues of FMRF-amide were custom synthesized by Bachem 
Laboratories. To allow the conjugation of dye to peptide, cysteine was added to FMRF-
amide to form CFMRF-amide (Cys-Phe-Met-Arg-Phe-NH2). Another related peptide 
from FMRF-amide is FLRF-amide. In this case, phenylalanine was replaced by cysteine 
and met was replaced by Leu to make CLRF-amide (Cys-Leu-Arg-Phe-NH2) which is 
also useful in conjugation. 
CHAPTER III 
RESULTS AND DISCUSSION 
The general objective of our synthetic work was to attach a dye molecule having a 
suitable A , and serving as a good generator of singlet oxygen, to several peptides. The 
max 
most general procedure would be to prepare derivatives of the dye which could be attached 
to a variety of peptides. We chose the commercially available Azure-Bas a good starting 
point to make derivatives of methylene-blue, a well known dye for generating singlet 
oxygen. 
The first synthetic step was the preparation of N-t-butoxycarbonyl-2-
chloroethylamine (.J). A common procedure reported by Tarbell and coworkers30 was 
followed involving a reaction of di-t-butyl dicarbonate (1) with 2-chloroethylamine 
hydrochloride (l.) at RT for 48 h. TLC, IR and 1 H NMR of the reaction mixture indicated 
that product was not formed. When the temperature was changed to reflux, all of the <li-t-
butyl dicarbonate reacted forming the desired product, but some 2-chloroethylamine 
remained unreacted. When the reaction was performed with a slight excess of di-t-butyl 
dicarbonate, IR and 1 H NMR indicated that the reaction went to completion. The liquid 
product was characterized by IR, lH NMR and 13c NMR spectroscopy. 
The second step was the reaction of N-t-butoxycarbonyl-2-chloroethylamine Cl) 
with the zwitterion of Azure-B (~). A zwitterion of Azure-B was first prepared with 
potassium tert-butoxide. It was then reacted with N-t-butoxycarbonyl-2-chloroethylamine. 
The reaction was attempted in different solvents such as THF, acetonitrile, methanol and at 
11 
12 
temperatures from RT to reflux. Also, it was essential that the solvent and the base should 
be non-nucleophilic. The best solvent for the reaction was found to be DMSO, and 
potassium tert-butoxide was used as a base. The temperature for the reaction was critical. 
It was found that above 150 °c the decomposition of Azure-B starts, while at 120-130 °c 
more by-products form. If the temperature is less than 90 °c, the reaction does not work. 
When the reaction was attempted in refluxing DMSO, the reaction mixture was a brownish 
black liquid. Column chromatography of this mixture yielded traces of the product and the 
NMR showed the presence of another decomposition product. The best conditions for the 
reaction were 100 °c in DMSO for 7 h. Under these conditions the product further 
decomposes to the desired dye-amine (S). HPLC of the reaction mixture showed the 
presence of three compounds. The most convenient method to remove the DMSO and the 
undesired decomposition products was column chromatography on silica gel. Fractions 
from the column chromatography were tested by HPLC. The DMSO and the 
decomposition products were eluted with methylene chloride; the unreacted Azure-B was 
eluted with 10% methanol in methylene chloride. The product (S) was eluted with 15% 
methanol in methylene chloride. 
+ ('r~X) HJC~ ~ N(CHy2 
c1· 
~ 
0 XA ~N~ 
O NHCHpI:!°~ s~N(CH) 
I + 32 
CH3 Ci° 
... 
Characterization of the product was based on 1 H NMR and reverse phase HPLC. 
Several attempts were made to find the best solvent system for the HPLC of this reaction 
13 
mixture. In one attempt 80% acetonitrile, 20% water and 0.1% TFA was used. This 
solvent system worked for the reaction mixture in which iodide was counter ion. 
However, the reaction mixtures with chloride counterion were completely retained by the 
column. When chloride is a counterion, the dye molecule is bound more tightly to the 
column due to strong Vander Weal's forces between the dye and the chloride. When the 
percentage of TF A was increased to 0.2%, the dye came out of the column. 
To improve the reaction yield, the same reaction was carried out in the presence of 
potassium iodide. The reaction mixture was analyzed by HPLC. With the exception of the 
counterion, the product composition was same as the reaction run without potassium 
iodide. It was found that conjugates with iodide counterion were not suitable for receptor 
binding studies, so this technique was not modified further. 
The next step was reaction of the dye-amine ~) with chloroacetyl chloride to form 
the chloroacetyl derivative (.6,) of the dye. It was essential that the solvent be 
nonnucleophilic as chloroacetyl chloride is very reactive and can react with a nucleophilic 
solvent. The best nonnucleophilic solvent used for this reaction was acetonitrile. The 
HPLC retention time was different than that for the dye-amine and the 1 H NMR confirmed 
formation of the desired chloroacetamide dye~. 
The chloroacetyl dye derivative (fil was coupled with the pentapeptide amide (1) in 
O. lM acetic acid in D20 at room temperature for 10 h to produce the desired blue dye-
peptide amide conjugate (ID. 
Cys-Phe-Met-Arg-Phe-NH2 
1 
+ 
" IH3 
/ NH- c- CH2-s-Cys- Phe- Mer- Arg - Phe - NH2 
fH2 ~N~ 
C~2M~ 
N S N(CHa)2 
I + 
CH 3 
14 
The coupling was done under acidic conditions as the peptides are stable in acidic 
solution. The cystine thiol group undergoes SN2 attack on ~- HPLC analysis using 
conditions where the chloroacetyl dye ~), the pentapeptide amide (']), and the conjugate (fil 
could all be distinguished showed only (fil after 10 h. A 5 h reaction time showed 
incomplete coupling. The 1 H NMR in D20 (see Experimental) showed the presence of 
methyl and aromatic protons from the dye, protons from the tether, and protons from the 
peptide in which some of the chemical shifts were different in the original peptide and the 
dye-peptide conjugate. 
Cys-Phe-Met-Arg-Phe-OH 
2 
Cys-Leu-Arg-Phe-Nfli 
1il 
Similar results were obtained when chloroacetyl dye (fil was coupled with 
pentapeptide-OH (2) and tetrapeptide-amide (!Q) to obtain the corresponding conjugates 
(11 and ll). All products could be distinguished on the HPLC system (see Table 1 
below). HPLC was done on a GOW-MAC instrument (Model No. 080-20) using a 30 
cm x 4.6 mm C-18 reverse-phase column, a 254 nm UV detector with 80% acetonitrile, 
20% water and 0.2% trifluoroacetic acid as eluant. 
+ 
0 NH3 
II I 
/NH- c- CH2-s-cys- Phe- Met--Arg- Phe-oH 
r2 ~N~ c~M~ 
N S N(CH :i)2 I + 
CH3 
11 
Table 1. HPLC of the Conjugates. 
Compound HPLC retention time in minutes 
Azure-B 33 
Dye-Amine 18 
Dye-chloride 17 .5 
Pentapeptide-amide 5.3 
Pentapeptide-amide conjugate (fil 21 
Pentapeptide-OH 5.5 
Pentapeptide-OH Conjugate (!1) 19.75 
Tetrapeptide-amide 6 
Tetrapeptide-amide conjugate (ll) 20.3 
15 
16 
Preliminary data on the efficiency of laser induced production of singlet oxygen 
shows a pH dependent enhancement of as much as 100% for the conjugates over 
methylene blue. Specific receptor binding studies in Helix Aspersa shows a 50% greater 
affinity of the pentapeptide amide conjugate .8. for the FMRFamide receptor site than for 
FMRFamide itself. The unconjugated pentapeptide amide showed a 2.5 times better 
binding than FMRFamide. Finally, preliminary electrophysiological experiments29 
confirm earlier reports that the FMRFamide receptor is inactivated by the pentapeptide 
amide conjugate .8. while it is not inactivated by a conjugate of the same amino acid 
sequence pentapeptide that is not a C-terminal amide. 
CHAPTER IV 
CONCLUSION 
We have developed a useful technique for covalently attaching a dye, with a 
chromophore similar to methylene blue, to a small peptide. Using this procedure on the 
tethered dye derivative 6, one can now make a number of potentially useful dye-peptide 
conjugates. We have demonstrated the technique by synthesizing derivatives related to 
FMRFamide. The utility of these conjugates can be inferred from initial studies in which 
the dye-peptide conjugates show good enhancement (values vary with pH) in singlet 
oxygen production over methylene blue and show receptor binding and electrophysiology 
activities comparable to the native peptides. Thus, we have developed a new tool for 
control of photodynamic therapy. 
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CHAPTER V 
EXPERIMENTAL 
Azure B, di-tert-butyl dicarbonate and 2-chloroethylamine monohydrochloride 
were obtained from Aldrich. The peptides, Cys-Phe-Met-Arg-Phe-NH2, Cys-Phe-Met-
Arg-Phe-OH and Cys-Leu-Arg-Phe-NH2, were purchased from Bachem. The infrared 
spectra were taken on Perkin-Elmer 1310 infrared spectrophotometer, and the NMR 
spectra were taken on a Varian VXR-300 instrument. Flash grade silica gel from Baker 
was used for the column chromatography. HPLC was done on a GOW-MAC instrument 
(Model No. 080-20) using a 30 cm x 4.6 mm C-18 reverse-phase column, a 254 nm UV 
detector with 80% acetonitrile, 20% water and 0.2% trifluoroacetic acid as eluant. TLC Rf 
values were measured on silica gel with methanol as eluent. UV spectra were measured on 
HP 8451 or PE 575 in D20. 
N-tert-Butoxycarbonyl-2-chloroethylamine (3): A 50 mL 2 neck RB flask fitted with a 
reflux condenser was charged with 690 mg (6.0 mmol) of 2-chloroethylamine 
monohydrochloride suspended in 10 mL of chloroform. To this mixture was added 1.2 g 
of sodium chloride and 504 mg (6.0 mmol) of sodium bicarbonate dissolved in 7.5 mL of 
water. Di-t-butyl dicarbonate (1.09 g, 5.0 mmol) was added, and the reaction mixture was 
refluxed for 2h. The reaction mixture was cooled to room temperature, and extracted with 
two 50 mL portions of chloroform. The chloroform extracts were combined, dried over 
anhydrous magnesium sulfate and the solvent was removed on a rotary evaporator to 
afford 850 mg of yellow liquid (4.7 mmol, 94 %). 1H-NMR (CDCl3) 5.25 (lH, broads, 
18 
19 
NH) 3.55 (2H, t, CH20), 3.4 (2H, q, CH2N), 1.4 (9H, s, t-Bu); 13C-NMR (CDCl3) 155.6, 
79.8, 44.2, 42.5, 28.3; IR 3400, 1680, 1715 cm-1; Rf (TLC)= 0.77. 
N-(2-Aminoethyl)Azure-B (5): A 50 mL 2-neck RB flask fitted with a condenser and 
addition funnel was charged with 62 mg (0.55 mmol) of potassium t-butoxide (K-t-
butoxide) and 10 mL of DMSO. The solution was stirred to dissolve K-tert- butoxide and 
170.4 mg (0.56 mmol) of azure-B, and 0.1 g (0.56 mmol) of N-tert-butoxycarbonyl-2-
chloroethylamine (J) were added to this solution. The solution was maintained at 100 °C 
for 7h. The color of the solution changed from purple to dark blue. The DMSO was 
removed using column chromatography. A silica gel (125 g) column was packed using 
methylene chloride. The reaction mixture (12 mL) was added to the column. 10% 
Methanol in methylene chloride (875 mL) was used to remove DMSO and other 
impurities, and the blue solid product (52 mg, 0.17 mmol, 30%) was eluted using 15% 
methanol (500 mL).1H-NMR (D20) 7.25 (2H, m, ArH), 6.8 (lH, m, ArH), 6.7 (lH, m, 
ArH), 6.55 (lH, s, ArH), 6.4 (lH, s, ArH), 2.93 (4H, m, CH2N), 2.93 (6H, s, (CH3)2N), 
2.68 (3H, s, CH3N); IR 3350, 3100 cm-1; A.max= 632 nm; Rf (TLC): Rf (Azure B) = 
0.02, Rf (N-tert-butoxycarbonyl-2-chloroethyl amine) = 0.77, Rf (.S) = 0.02; HPLC: 
Retention times (min) 18 (5), 33 (Azure-B). 
N-(2-Chloroacetyl amidoethyl)Azure-B (6): A 50 mL 3 neck RB flask fitted with a 
condenser was charged with 4.3 mg (0.013 mmol) of the amine (fil and 15 mL of 
acetonitrile. To this solution was added 0.01 mL (3 mmol) of chloroacetyl chloride. The 
solution was stirred at room temperature under N2 for 12 h. The solvent was removed on 
20 
a rotary evaporator to obtain a blue solid (5.1 mg, 0.013 mmol, 100%). 1H-NMR 
(CDCl3) 8.93 (lH, s, ArH), 8.91 (lH, s, ArH), 8.47 (lH, t, J = 7.0, ArH), 7.98 (3H, t, J 
= 7.0, ArH),3.68 (2H, s, ClCH2CO), 3.38 (4H, m, NCH2CH2N), 2.71 (9H, pseudos, 
CH3N); IR 3100, 1710 cm-
1; A.max= 629 nm; Rf TLC (Silica gel/methanol): Rf (Dye 
amine) = 0.02, Rf (chloroacetyl chloride) = 0.78, Rf (Reaction mixture) = 0.04, 0.78. 
HPLC: Retention time (min) 17 .5 ~). 
Cys-FMRF-amide analoeues: The pentapeptide and tetrapeptides were custom 
synthesized and analyzed by Bachem Bioscience (Philadelphia). HPLC analysis disclosed 
a 99% purity of the analogues, and a minimal ( < 1 % ) disulfide coupling. A 300 MHz 1 H 
NMR spectra confirmed the structure of the peptides. 
Table 2. lH NMR of Penta peptide Amide (1) in D20 
Cys-Phe-Met-Arg-Phe amide 
Expected chemical shifts 
Residue aH 
Cys 4.69, lH 
Phe 4.66, 2H 
Met 4.52, lH 
Arg 4.38, lH 
SH 
3.28, 2.96, 2H 
3.22, 2.99, 4H 
2.15, 2.01, 2H 
1.89, 1.79, 2H 
lOH 
Others 
7.3, 7.39, 7.30, lOH, ArH 
2.64, 2.64, 2H, JCH2 
2.13, 3H, ECH3 
1.70, 1.70, 2H, JCH2 
3.32, 3.32, 2H, OCH2 
19H 
Observed chemical shifts 
Residue aH ~H 
Cys 4.52, lH 3.5, 2.7, 2H 
Phe 3.56, 2H 2.9, 2.75, 4H 
Met 4.19, lH 2.2, 2H 
Arg 4.0, lH 1.26, 1.09, 2H 
5H lOH 
Table 3. lu NMR of Pentapeptide-OH (2.) in D20 
Cys-Phe-Met-Arg-Phe-OH 
Expected chemical shifts 
Residue aH ~H 
Cys 4.69, lH 3.28, 2.96, 2H 
Phe 4.66, 2H 3.22, 2.99, 4H 
Met 4.52, lH 2.15, 2.01, 2H 
Arg 4.38, lH 1.89, 1.79, 2H 
5H lOH 
Others 
7 .0-7 .2, lOH, ArH 
2.75, 2H, J'CH2 
1.85, 3H, eCH3 
1.46, 1.7, 2H, J'CH2 
2.9, 2H, 8CH2 
19H 
Others 
7.3, 7.39, 7.30, lOH, ArH 
2. 64, 2. 64, 2H, yCH 2 
2.13, 3H, eCH3 
1.70, 1.70, 2H, J'CH2 
3.32, 3.32, 2H, 8CH2 
19H 
21 
Observed chemical shifts 
Residue cxH PH Others 
Cys 4.28, lH 2.89, 2H 
Phe 4.28, 3.12, 2H 2.89, 2.78, 4H 7 .0-7 .2, lOH, ArH 
Met 4.15, lH 2.22, 2H 2.78, )'CH2 
1.84, 3H, eCH3 
Arg 4.05, lH 1.3, 2H 1.48, 1.7, 2H, )'CH2 
2.89, 2H, 8CH2 
5H lOH 19H 
Table 4. 1 H NMR of Tetrapeptide Amide (!!!) in D20 
Cys-Leu-Arg-Phe-NH2 
Expected chemical shifts 
Residue cxH 
Cys 4.69, lH 
Phe 4.66, lH 
Leu 4.38, lH 
Arg 4.38, lH 
4H 
PH 
3.28, 2.96, 2H 
3.22, 2.99, 2H 
1.65, 1.65, 2H 
1.89, 1.79, 2H 
8H 
Others 
7.3, 7.39, 7.30, 5H, ArH 
1.64, lH, )'CH2 
0.94, 0.90, 6H, OCH3 
1.70, 1.70, 2H, )'CH2 
3.32, 3.32, 2H, 8CH2 
16H 
22 
23 
Observed chemical shifts (D20) 
Residue a.H ~H Others 
Cys 4.4, lH 2.92, 2H 
Phe 4.2, lH 2.92, 2H 7 .05-7 .2, 5H, ArH 
Leu 4.2, lH 1.45, 2H 1.33 , lH, )'CH2 
0.7, 0.75, 6H, 8CH3 
Arg 4.05, lH 1.45, 2H 1.45, 2H, JCH2 
3.15, 2H, 8CH2 
4H 8H 16H 
Coupline of dye-chloride (6) with Pentapeptide-amide (1).;. To a 50 mL RB flask was 
added 1.2 mL of D20 and 5.7 µL of acetic acid under N2. The solution was degassed by 
repeated freeze pump thaw cycles under vacuum. The dye-chloride (6) (0.55 mg) was then 
added, followed by 1 mg of pentapeptide-amide (JJ. The solution was degassed and left 
under N2 at room temperature for 10 h. After 10 h, the solution was lyophilized and a 
blue colored solid (8) was obtained. HPLC, UV spectra (A = 628 nm, £=14090) and 
max 
300 MHz 1H-NMR are consistent with the structure. HPLC: Retention times (min) 5.3 
(Pentapeptide-amide), 21 (Pentapeptide-amide conjugate). 
Table 5. lH NMR of Pentapeptide-Amide (8) Conjugate in D20 
Residue 
Cys 
Phe 
Met 
Arg 
Dye 
aH 
4.52, lH 
4.25, 4.08, 2H 
4.42, lH 
4.01, lH 
5H 
~H 
2.9, 2.7, 2H 
2.9, 2.75, 4H 
2.2, 2H 
1.26, 1.09, 2H 
lOH 
Others 
7.0-7.2, lOH, ArH 
2.75, 2H, )'CH2 
1.85, 3H, eCH3 
1.46, 1.7, 2H, )'CH2 
3.1, 2H, 0CH2 
7.4, 2H, ArH 
7.1, lH, ArH 
6.86, 2H, ArH 
6.68, lH, ArH 
3.07, 6H, CH3 
2.9, 2.5, 4H, - CH2CH2-
2.8, 3H, CH3 
2.5, 2H, CH2S 
40H 
24 
Coupline of dye-chloride (6) with Pentapeptide-OH (2};. To a 50 mL RB flask was 
added 1.2 mL of D20 and 5.7 µL of acetic acid under N2. The solution was degassed by 
repeated freeze pump thaw cycles under vacuum. The dye-chloride ~) (0.55 mg) was then 
added, followed by 1 mg of pentapeptide-OH (2). The solution was degassed and left 
under N2 at room temperature for 10 h. After 10 h, the solution was lyophilized and a 
25 
blue colored solid (.11) was obtained. HPLC, UV spectra (A = 628 nm, £=13290) and 
max 
300 MHz 1H-NMR are consistent with the structure. HPLC: Retention times (min) 5.5 
(Pentapeptide-OH), 19.75 (Pentapeptide-OH conjugate). 
Table 6. lH NMR of Pentapeptide-OH Conjugate (ll) in D20 
Residue 
Cys 
Phe 
Met 
Arg 
Dye 
a.H 
4.28, lH 
4.28, 3.12, 2H 
4.15, lH 
4.05, lH 
5H 
~H 
2.89, 2H 
2.89, 2.78, 4H 
2.22, 2H 
1.3, 2H 
lOH 
Others 
7.0-7.2, lOH, ArH 
2.78, "fCH2 
1.84, 3H, cCH3 
1.48, 1.7, 2H, "fCH2 
2.89, 2H, 0CH2 
7.59, 2H, ArH 
7.1, lH, ArH 
6.89, 2H, ArH 
6.72, lH, ArH 
3.12, 2.95, 6H, CH3 
3.15, 2.5, 4H, - CH2CH2-
2.82, 3H, CH3 
2.53, 2H, CH2S 
19H 
Coupline of dye-chloride (6) with Tetrapeptide-amide (J.J!).:,To a 50 mL RB flask was 
added 1.2 mL of D20 and 5.7 µL of acetic acid under N2. The solution was degassed by 
26 
repeated freeze pump thaw cycles under vacuum. The dye-chloride ~) (0.55 mg) was then 
added, followed by 1 mg of tetrapeptide amide @). The solution was degassed and left 
under N2 at room temperature for 10 h. After 10 h, the solution was lyophilized and a 
blue colored solid (.ll) was obtained. HPLC: Retention times (min) 6 (Tetrapeptide-
amide ), 20.3 (Tetrapeptide-amide conjugate). HPLC, UV spectra (A. = 626 nm, 
max 
£=14428) and 300 MHz 1H-NMR are consistent with the structure. 
Table 7. lH NMR of Tetrapeptide-Amide Conjugate ill) in D20 
Residue 
Cys 
Phe 
Leu 
Arg 
Dye 
a.H 
4.4, lH 
4.2, lH 
4.2, lH 
4.05, lH 
4H 
~H 
2.92, 2H 
2.92, 2H 
1.45, 2H 
1.45, 2H 
8H 
Others 
7.05-7.2, 5H, ArH 
1.33 , lH, ,.CH2 
0.7, 0.75, 6H, 8CH3 
1.45, 2H, ,.CH2 
3.15, 2H, 8CH2 
7.2, lH, ArH 
7.49, 2H, ArH 
6.88, 2H, ArH 
6.71, lH, ArH 
3.1, 2.95, 6H, CH3 
3.21, 4H, - CH2CH2-
2.9, 3H, CH3 
2.03, 2H, CH2S 
37H 
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PartB 
Synthesis of A Novel Bicyclic Triene 
CHAPTER I 
STATEMENT OF THE PROBLEM 
The objective of this project is to synthesize bicyclo[4.4.2]dodeca-3,8,11-triene (1). 
1 
The synthesis will be achieved in six steps from known tetraethyl cis,cis-3,8-
cyclododecadiene-1, 1,6,6-tetracarboxylate @. 
NaOEt EtOOC COOEt NaCl COO Et 
/COOEt EtOH CJ DMSO CJ CCI+ CH2' > Cl COO Et 65 - 70 cc Reflux 
Sb EtOOC COOEt 24b COO Et 
i ~ ~ 5. 
Na/K as c6 Xylene Zn/Hg NH1NHTs .,... )Ill" ~ Reflux 4M-HC1 Ethanol 
(i 1 
cf)s BuLi dJ I ~ Diglyme 
~ 1 
51 
(!). 
CHAPTER II 
INTRODUCTION 
The objective of our research is to synthesize bicyclo[4.4.2]dodeca-3,8,11-triene 
1 
A synthesis of this compound has never been reported, but syntheses of other 
compounds with similar carbon skeletons have been reported (see below). 
Scientists have been interested in synthesizing molecules that have interesting 
shapes such as cubane (.2.), adamantane (lJ!.), buckminsterfullerene (ll) etc. 
Buckminsterfullerene I has 60 carbon atoms. The atoms are arranged in 12 pentagons and 
20 hexagons. It has a soccerball like symmetrical structure, and was isolated from soot. 
11 
As the name suggests, Cubane is a cube like structure and can be synthesized from 
cyclobutadiene irontricarbonyl in four steps.2 The syntheses of 10and11 are much less 
52 
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straightforward. Our idea was to synthesize a molecule that had an interesting shape and 
could be used to synthesize other molecules that have interesting shapes and symmetries. 
Syntheses of several interesting compounds with a general formula (CH)n have 
been reported. One important compound from the C6H6 family is prismane W). 
Hexamethylprismane was synthesized by irradiating 
hexamethylbicyclo[2.2.0]hexa-2,5 diene. 3 Prismane is a molecule in which six sp3 carbon 
atoms are present at corners of a triangular prism. It was synthesized from benzvalene 
(U) in three steps.4 Benzvalene was reacted with 4-phenyltriazolinedione (li) to obtain an 
adduct. It gave an azo compound by treatment with acidic CuCl2 followed by reaction 
with aqueous NaOH. Photolysis of the azo compound led to the formation of prismane. 
0 ~ ct+ NJ< ~iN-C6H5 N~N OAN~O 
0 I 
C6H5 
li ~ 
1. Acidic Cu Cl 2 ~ hv ~ ...... 2. NaOH 
N=N 
16 12 
54 
Another interesting C6H6 hydrocarbon is Dewar benzene. 1,2,5-tri-t-
butylbicyclo[2.2.0]hexa-2,5-diene (a Dewar benzene) (1fil was synthesized by a photolysis 
of 1,2,4-tri-t-butylbenzene (11). 5 In this case the product cannot revert to the starting 
material as it violates orbital-symmetry rules. 
t-Bu 
t-Bu 
hv 
' L:::.. 
t-Bu 
t-Bu ~ t-Bu t-Bu 
t-Bu ,Pi Conrotatoz_ H li t-Bu 
t-Bu 
1Z 
Vogel reported a synthesis of 1,6-methano[lO]annulene and 1,6-oxido[lO]annulene 
(15.) from naphthalene @). 6 Naphthalene was reduced by Birch reduction to obtain 
tetrahydronaphthalene (ll). Selective oxidation of the double bond gave an epoxide (ll) 
which gave 1,6-oxido[lO]annulene (ZS,) by Vogel's technique. Vogel brominated a diene, 
followed by dehydrobromination to yield a bicyclic tetraene 24 which rearranged to ZS.. 
Na/NH~ 00 
21 
0 
Br~Br 
Br~Br 
ZJ 
Base 
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The aromatic nature of the product is confirmed by its chemical nature. It is stable 
towards heat. oxygen and light. It undergoes substitution reactions with electophiles. 
Vogel also reported syntheses of 1.6,8,13-bisoxido[l4]annulenes (31a. h.).6 
1,4,5,8,9,10-hexahydroanthracene was prepared by Birch reduction of anthracene @). On 
peracid oxidation, it gave two isomeric diepoxides (28a. hl which on bromination gave 
tetrabromo adducts (29a, .h). Base treatment of these adducts gave 1,6,8, 13-
bisoxido[ 14 ]annulenes. 
0 
000 
Br Br2 
...... 
Br 
Na/ NH3 
56 
0 
31b 
cco I ~ 
57 
When 9,10-dihydronaphthalene (32) was irradiated with UV light, it rearranged to 
form two compounds.7 One is bicyclo[4.2.2]deca-2,4,7 ,9-tetraene ~). an important 
intermediate in the formation of bullvalene. It rearranged to form bullvalene (M) in high 
yield on ultraviolet irradiation. 
hv hv 
245 °c 
Ultraviolet irradiation of bullvalene (~ formed different products.9 
Photolysis of 38, 39 and 40 gives tetracyclo[4.4.0.o2,10.o5,7]deca-3,8-diene (fil 
which is an important intermediate discussed in many important (CH) 1 o hydrocarbons. 17 
58 
JH 
co hv CD Q) L::.. ~ .& 
32 41 il 
co y .& 
.40 
Thermal decomposition of (.4.J.) gave bicyclo[5.2.0]nona-2,4,8-triene (44), 
bicyclo[ 4.2. l]nona-2,4,7-triene (_4S) and bicyclo[3.2.2]nona-2,6,8-triene ~). 8 
+ 
CHNNTsNa 
.4J 
PaquettelO was interested in the interconversion of (CH)12 hydrocarbons. It is an 
interesting family of compounds with theoretical significance and several electrocyclic and 
sigmatropic processes are observed for different isomers. However, not much work has 
been reported due to the unavailability of good synthetic routes for these compounds. 
Schroder and Paquette have reported 11 a synthesis of tetraene .48.a from cis,syn,cis 
tricyclo[8.2.0.0 2,9]dodeca-3,5,7,11-tetraene (!'Z) by thermal rearrangement. 
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The same compound, exo-tricyclo[ 4.4.2.0. 7' 1 O]dodecatetraene (fu) was 
synthesized 10 by reacting cyclobutadieneiron tricarbonyl with eerie ammonium nitrate in 
' 
the presence of a cis, trans mixture of 7, 8-dichlorobicyclo[4.2.0]octadiene (Sta. b) to 
obtain Diels-Alder adducts. The adducts were reacted with sodium phenanthrene to obtain 
a triene which on pyrolysis at 500 °c yields a tetraene. 
dCI Cl 
Ce2+ ~CI ~Cl ~ + Cl + Acetone 
Fe(C0)6 
49 Sil fu fil 
Na-Phenanthrene ~ Qt) ... Do ~ 
THF 
52a 48a 
Photoisomerization of this tetraene in ether gave a mixture of two isomeric trienes 
(52a. h) in equal amounts. IO 
hv 
60 
Formation of the above tetraene is speculated to take place via a strained pentaene 
W intermediate. However, this pentaene was never isolated or synthesized by a different 
route. 
Formation of the cyclobutene ring relieves strain in the tetraene. Erhardt12 reported 
a synthesis of these isomeric trienes (Slib hs t) from a carbonate in four steps. 
On benzophenone sensitized irradiation in ether, the third triene gave a cage 
compound ~). 
The following pentaene on heating gave benzocyclotetraene (S.6). 
430°C 
Gas phase 
61 
The following cyclobutene derivative (57) on photoisomerization in pentane gave 
exo-tricyclo[4.4.2.0.7,10] dodecatetraene (48a) which resulted in a formation of two 
isomeric trienes ~ ]!).13 
hv 
Paquette14,15 has reported a synthesis of [4.4.2]propella-3,8,11-triene (@) by 
Ramberg-Backlund rearrangement of cx.-chlorosulfone (S2) with K-tert-butoxide. The cx.-
chlorosulfone was prepared by chlorination and subsequent oxidation of the corresponding 
sulfide (.58). 
Cl 00 00 1. Chlorination ~ K-tert-butoxide ~ ~ 2. Oxidation TIIF 
S8 S2 @ 
An alternate route15 was used for the synthesis of [4.4.2]propella-3,8,11-triene 
(~.In this approach, dimethyl ~2,6-hexalin-9,10-dicarboxylate (fil) was reacted with 
Na/K alloy to form the corresponding hydroxy-ketone ~- It was reduced to a mixture of 
cis and trans diols (63) by LiAlH4. The cis-diol was converted to cis-thiocarbonate ester 
~) which was then reacted with trimethyl phosphite to form the triene (@). 
62 
0 OH 
COOCH3 Heb H Cb Na/K ~ I I LiAIH4 ~ 
COOCH3 
fil ~ 
A synthesis of [4.4.2]propella-2,4,7,9,11-pentaene (n6.) has been reported16 from 
the corresponding a.-chlorosulfone ~). 
K-tert-butoxide cb7 ~ 
~ 
Another interesting synthesis of a tricyclic compound has been reported. A series 
of three reactions was used to make the third ring (jH). 
1. CH2N2 
CH2COOH 2. NaOC2H5 Cb 3. H30+ ~ CG 
CH2COOH 
fil ~ 
63 
Ginsburg 17 has reported a synthesis of a trienic[ 4.4.4]propellane from a diester. 
The bicyclic diester (69) was converted into a triene (70) in five steps. 
~OOCH3 
 5Steps~ CQ) 
CH2COOC83 
62. 
Bicyclo[4.4.2]dodeca-1,3,8,l l,13-pentaene (SJ.) can also be synthesized from the 
ketone (7) which is a precursor of the triene (1), using Vogel's technique. Bromination of 
diene double bonds followed by dehydrobromination of the tetrabromide to obtain a 
tetraeneone (11) which can be converted into a pentaene using the same technique that was 
used to make the triene. 
0 
c6 Vogel --Technique 
1 71 
This pentaene (SJ.) could have several synthetic uses. It could undergo thermal 
[4+2] cycloaddition to form unsymmetrical bicyclopropane derivative (1.J). Photochemical 
[4+4] addition in this compound should lead to the formation of a symmetrical 
bicyclopropane derivative (74), while [2+2] photochemical cycloaddition should give a 
mixture of two tetraenes (.483,. .h). One of the isomeric trienes (lli) has a geometry such 
that the two double bonds can undergo 2+2 photochemical cycloaddition to form basketene 
compound~) as previously reported (see below). 
64 
cb A ~ ~ # 
SJ u 
hy ~ 
Ji + ~ 
~ ~ 74 
l hv ~ 
+ w + ~ 
fil lli .sk fil 
J hv 
Synthesis of some of these products has been reported in the literature and was 
discussed before. Since these compounds are already characterized, it will be easy to 
identify the reaction products of the pentaene. 
CHAPTER III 
RESULTS & DISCUSSION 
A literature procedure18•19 was used for the synthesis of the tetraethyl cis,cis-3,8-
cyclodecadiene-1, 1,6,6-tetracarboxylate ~). 
CCI /COOEt 2 + CH2, Cl COO Et 
z J 
NaOEt 
Et OH 
65-70 °C 
5h 
EtOOC COOEt 
EtOOC COOEt 
~ 
The major limitation of this procedure is the 2.6% yield of tetraester, and several 
attempts were made to improve the yield. To find whether slow addition would improve 
the reaction yield, 1,4-dichloro-2-butene was added to the sodium salt of diethyl malonate 
over 5 hr and 12 hr. The yield stayed the same. In another attempt, the solvent was 
changed to xylene and sodium carbonate was used as base. When the reaction was done at 
reflux, no product was obtained due to the insolubility of sodium carbonate in xylene. The 
same result was obtained twice. In one reaction, it was found that the yield of the tetraester 
decreased when the reaction temperature was lower than 65 to 75 °C. However, when the 
reaction was carried out in refluxing ethanol, the yield did not increase. An attempt was 
made to improve the yield of tetraester by adding l ,4-dichloro-2-butene to the sodium salt 
of diethyl malonate, but the yield did not improve. Thus it appears that for the tetraester 
synthesis, the best set of conditions is the one reported in the literature. 18•19 However, we 
found that the best yield was obtained only after modifying that procedure. A heating tape 
65 
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was used to keep the sodium salt of diethyl malonate above its melting point. A 
mechanical stirrer was used to stir the solution at high speed to allow immediate mixing of 
the components. The best yield was 2.6%, and the research was continued using that yield 
of tetraester @. 
The literature 19 used methanol for recrystallization of tetraester ~). However, we 
found that a chlorofonn/petroleum ether mixture makes the recrystallization considerably 
easier. 
This tetraester is an important sta1ting material in our research. Major products of 
the reaction were diethyl cyclopent-3-ene-1,1-dicarboxylate (74) and diethyl 2-
vinylcyclopropane-1,1-dicarboxylate <1.S) (67% total). We investigated the reaction to find 
other unreported products (33%) of the reaction. 
During the workup, the major volatile products were removed by vacuum 
distillation. The residue was washed with heptane to obtain crude tetraester. Compounds 
in the heptane washing were separated by column chromatography and two pure 
compounds were isolated. One of them was diethyl 2,7-dicarboethoxy-octa-4-enedioate 
(Zfil and the other is diethyl 2,7,7,12-tetracarboethoxy trideca-4,9-dienedioate (12). 
C COOEt COO Et COOEt COO Et 
Ev Et 
EtOOC o o COOEt 
00 
00 
mm 
- -77 
EtOOC COOEt 
~ 
Cl Cl 
Characterization of these products suggests the presence of diethyl 1,9-
dichloronona-2,8-diene-5,5-dicarboxylate {18) as a reaction intermediate. This intermediate 
further reacts with diethyl malonate dianion to form the desired tetraester. Isolation of 
these intermediates clarifies the mechanism of tetraester ~) formation. As seen in the 
67 
proposed mechanism, there are several competing reactions. Formation of the two major 
products 74 and 75 are kinetically favored, hence they form in high yield. Two competing 
reactions are formation of diethyl l,9-dichloronona-2,8-diene-5,5-dicarboxylate (~)and 
diethyl 2,7-dicarobethoxy-octa-4-enedioate (76). Out of these two, the dichloride @ is an 
intermediate for tetraester (.4). When this dichl01ide reacts with one equivalent of diethyl 
malonate, it forms the desired tetraester by ring closure. Reaction with two equivalents of 
the diethyl malonate forms the undesired hexaester 77. 
1(\..., COOEt faCOOEt 
lLJ' COOEt - COOEt 
74 
NaOEt 1 faaOEt 
CCI Cl / COOEt NaOEt + CH 2, COO Et f'<c88~f ~COOEt COO Et 
J NaOEt 
EtO~OEt 
~ ~ 
Cl Cl 
18 
JNa~Et 
EtOOC COOEt 
C) 
EtOOC COOEt 
~ 
J 1!i 
NaOEt EtOOC COOEt 
~ )? 
EtOOC n n COOEt 
00 
00 
tr1 tr1 
............ 
77 
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Due to the high boiling points of the components in tetraester washings, GC cannot 
be used for its analysis. The tetraester washing was decarboalkoxylated using the Krapcho 
method. 20 The GC of this reaction mixture showed the presence of two major products in 
56 and 44% yield in the tetraester washing. 
Tetraester ~was decarboalkoxylated using Krapcho's technique20 to obtain diester 
.s_. When the tetraester was refluxed in NaCl/DMSO for 24 hours under a nitrogen 
atmosphere, the desired diester S. was obtained. Further modifications in the workup 
procedure gave 78 % yield of the diester .S.. Although the spectra clearly identified the 
cyclic diester, the stereochemistry of the crystals was uncertain. 
EtOOC COOEt 
w 
EtOOC COOEt 
~ 
NaCl 
DMSO 
Reflux 
24h 
COO Et 
w 
COO Et 
s. 
Good quality diester crystals were obtained by recrystallizing from DMSO. 
Dimensions of these crystals are 4mm x Imm x 0.5mm. The quality of these crystals was 
suitable for X-Ray crystallography. Structure elucidation was done in collaboration with 
Dr. Pavkovic. X-Ray crystallography indicated that the two ester groups are in the trans 
conformation. 
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For the acyloin reaction to work, these two ester groups should be cis. The gas 
chromatographic analysis of the solution part of the acyloin reaction mixture revealed the 
presence of two isomers of the diester. The GC-mass spectra showed that these two peaks 
have the same molecular weight and the same fragmentation pattern. This confirms that 
two isomers of the diester were present in the reaction mixture of the acyloin reaction. 
However, the initial diester showed only one peak in GC under the same conditions. It 
appears that epimerization of the trans-diester takes place during the acyloin reaction to 
form a cis-diester which then reacts to form the corresponding hydroxy-ketone. 
Two low energy conformations were computed with PC model using trans-1,10-
dimethyl-3,8-cyclodecane as a model. The minimum energy conformation agreed with the 
conformation of the diester .S. obtained by X-ray crystallography. Similar calculations done 
on the cis-diene show three minimum energy wells, the lowest of which has an energy 
70 
similar to trans-diene. This result clarifies the epimerization of diester .S.. Minimum 
energy conformations tend to be staggered. Examining the eclipsed conformation which 
would be intermediate in the acyloin closure, one finds a 9 to 12 KcaVmole barrier. 
The next reaction was the acyloin reaction of this diester CS) to form a disilyl ether 
W).21 Acyloin reaction involves a reaction of a diester with Na or Na/Kin inert solvent 
to form a hydroxy-ketone. The mechanism of this reaction is as follows. 
O~ /OEt oo 
COO Et C· CT5 w • w 2Na ~ ~ I I 
COO Et c· 0/ "'-OEt 
s. 12 
as as as 2 Na• 2H+ ~ I ~ I ~ 
.81 81 fi 
This reaction can be done with or without TMSCL In the presence of TMSCl, the 
intermediate dianion (81) is trapped to form a disilyl ether (,83), which can be hydrolyi.ed to 
form the hydroxy-ketone ~). In the absence of TMSCl, hydroxy-ketone is obtained 
directly. 
To test the technique of the reaction, dimethyl adipate was refluxed with Na/toluene, 
TMSCl under nitrogen for 5 h. The reaction proceeded smoothly and the yield of the silyl-
71 
ether was 60%. Further reaction of this silyl-ether with methanol gave 2-hydroxy-
cyclohexanone in 98% yield. 
COO Et Na/K Ma5e3 
CJ Xylene ~ Reflux 
COO Et 
s 83 
However, when the diester (S) was reacted under the same conditions, hardly any 
of the diester underwent reaction to form the disilyl-ether (BJ.). To obtain the desired 
product in this reaction, it is essential to have anhydrous conditions. The reaction was 
carried out under the same conditions with a bigger quantity of the diester and more careful 
drying of toluene and TMSCI. The yield did not change. Since this reaction takes place at 
the metal surface, particle size of the suspended sodium metal is important. The smaller 
the particle size of the sodium suspension, the larger the area of sodium surface, and the 
faster the reaction should go to completion. Hence the reaction was again carried out using 
a 50% suspension of sodium in mineral-oil, available from Aceton Associates. The yield 
did not change. These facts indicated that the problem was not with the anhydrous nature 
of the toluene and TMSCl or with the suspension of the sodium metal. 
To find the root of the problem, tetraester ~ was reacted under the same conditions. 
If the problem is with the conformation of the diester (S), the tetraester ~ should react under 
these conditions, as it definitely has two cis ester linkages.19 However, if the problem is 
with the reaction conditions, the tetraester will not react. It was found that the tetraester 
72 
also barely reacted. This clearly indicated that problem was the reaction conditions. When 
the tetraester was reacted in refluxing xylene, NMR analysis of the reaction mixture 
showed increased formation of the desired product. This indicated that the probable cause 
of failure of the silylation was the reaction conditions. Hence the diester was refluxed again 
with Na/TMSCl in xylene and the yield of the desired product significantly improved. 
When the reaction was carried out with Na/K, the yield increased some more. When Na/K 
alloy was prepared with more care, almost all of the diester reacted. The IR spectrum of 
the reaction mixture shows a weak carbonyl stretch at 17 40 cm-1 indicating a trace of the 
unreacted diester. 
When the disilyl-ether ~was reacted with methanol under N2 at RT, a yellow 
colored liquid was obtained. The IR spectrum of this liquid showed the presence of a 
carbonyl stretch at 1700 cm·1 and the hydroxy stretch at 3300 cm-1• The literature4 
indicates that the disilyl-ether should be distilled before reaction with methanol and the 
reactivity of this compound decreases with the age of the compound. The distillation was 
unsuccessfully attempted twice. 
The acyloin reaction mixture was separated using column chromatography. The 
fraction collected with ethyl acetate showed the presence of hydroxyl and carbonyl in the IR 
spectra. However impurities of silylated compounds were found in all the fractions. The 
same result was obtained in four different attempted separations. Probably an excess of 
TMSCl formed undesired silyl compounds which interfered with the separation. Hence 
the reaction was run in absence of TMSCI. The reaction mixture was separated by column 
chromatography. The IR spectrum of the 20% ethyl acetate in petroleum ether fraction 
showed a hydroxy peak at 3300 cm-1 and a carbonyl stretch at 1700 cm-1• Since the diester 
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absorbs at 1725 cm-1, this must be the hydroxy-ketone. 1H-NMR spectrum of this fraction 
showed a peak at 3.62 ppm. 13C NMR analysis of this reaction mixture showed a ketone 
carbonyl peak at 221 ppm. High resolution mass spectrum of the hydroxy-ketone, purified 
by column chromatography, showed a mass of 192.1142 while calculated molecular 
weight of the desired hydroxy-ketone is 192.1150. This proves formation of the hydroxy-
ketone in the acyloin reaction without TMSCl. Although the reaction did not go to 
completion, pure hydroxy-ketone (~) was obtained when the acyloin reaction was run in 
the absence of TMSCl. Hence the best choice was to run this reaction in the absence of 
TMSCl. 
COO Et Na/K as CJ Xylene > Reflux 
COO Et 
s (! 
The diester was reacted with Na/K in refluxing xylene for 24 h to obtain the 
hydroxy-ketone (~). In an attempt to improve the yield of the product, the reaction was 
carried out for 6 hand 12 h. However, a larger quantity of the diester stayed unreacted. 
Hence, 22 h reflux is the best condition for this reaction. Purity of the hydroxy-ketone~ 
was confirmed by TLC. 
The next reaction of this hydroxy-ketone ~) is a Clemmensen reaction22•23, to 
selectively remove the hydroxy group without affecting the ketone (1). Clemmensen 
reduction is generally used to reduce a carbonyl to a methylene group. The selective 
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reduction of the alpha hydroxy group in a hydroxy-ketone can be achieved by using 4M-
HCl and Zn/Hg. The reaction was carried out on a model compound of 2-
hydroxycyclohexanone. This model compound was reacted with Zn/Hg in 4M-HC1 under 
reflux for two hours. Comparison of the IR spectrum of the hydroxy-ketone with the 
reaction mixture showed loss of the hydroxy peak and formation of a new carbonyl peak at 
The hydroxy-ketone (fil was selectively reduced to the ketone 7. using Zn/Hg and 
4M-HC1for2 1/2 h. 1H-NMR and GC analysis indicated that the reaction worked. lH 
NMR analysis indicated a change in the 3.62 ppm region. IR spectrum showed a less 
intense hydroxy peak as compared to the hydroxy-ketone (fil. The product was not 
separated due to the small quantity of material involved. 
Zn/Hg 
4M-HCI 
1 
Energy minimization calculations were performed on the three possible ketone 
conformations using PC model. It indicated that they have comparable stabilities. 
0 0 
0 
.Tu Th 'k. 
mmx Energy 37.06 Kcal/mole 35.38 Kcal/mole 36.08 Kcal/mole 
Strain Energy 32.43 Kcal/mole 30.86 Kcal/mole 32.01 Kcal/mole 
Heat of 3.59 Kcal/mole 1.92 Kcal/mole 2.61 Kcal/mole 
Formation 
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X-ray crystallography has indicated that conformation of the diester (S.) is trans 
with the two rings pointing away from each other. The ketone should also have the same 
conformation as the diester. The orientation of the carbonyl group in the ketone (.'.Z.il) is 
such that it pushes the neighboring hydrogens in the shielding zone. As a result, these 
protons absorb at 3.6 and 4.1 ppm in 1 H NMR. 
The next step was conversion of the ketone to an alkene by the Shapiro reaction. 24 
In this reaction, a ketone is first converted to its tosylhydrazone derivative. The 
tosylhydrazone is then reacted with butyllithium to obtain the alkene. 
Ethanol 
dSHTs 
1 
To test the technique of the Shapiro reaction, 1 '-acetonaphthone was reacted with 
tosylhydrazide in ethanol under reflux. Within one hour the flask was filled with white 
solid as the product precipitated out of solution. The ketone (1) was refluxed with 
tosylhydrazide in ethanol for six hours to obtain a solid. 1 H NMR spectrum showed the 
presence of tosylhydrazide peaks along with tosyl hydrazone peaks. 1 H NMR spectrum of 
B also showed upfield shift of protons that were at 3.6 ppm in the ketone (1). As nitrogen 
is less electronegative than oxygen, this shift confirms the formation of tosylhydrazone. 
Most of the unreacted tosylhydrazide was removed by washing with chloroform. 
d5NN,HTs __ __ BuLi ... Diglyme 
B 
m 
1 
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The tosylhydrazone (.8) was reacted with BuLi in diglyme at 60 °c for 4h. The 
reaction mixture was separated by column chromatography. The desired triene (1) was 
eluted with petroleum ether. 1 H NMR shows some confirming evidence for the formation 
of 1. 
CHAPTER IV 
CONCLUSIONS 
Tetraethyl cis,cis-3,8-cyclodecadiene-1,1,6,6-tetracarboxylate ~was prepared in 
2.6% yield using the literature procedure. Two products of the reaction of 1,4-dichloro-2-
butene and diethyl malonate are isolated for the first time. Characterization of these 
products explains the mechanism of the formation of tetraethyl cis,cis-3,8-cyclodecadiene-
l, l ,6,6-tetracarboxylate (~. Some modifications in the apparatus and the workup that 
made the procedure considerably easier, are also reported. Krapcho decarboalkoxylation of 
this tetraester stereospecifically gave a trans isomer of the corresponding diester (S). 
Acyloin reaction of this diester gave the hydroxy-ketone (fil via cis-diester which was 
formed by epimerization of the trans-diester under the reaction conditions. Hydroxy-
ketone ~ has been completely characterized. The pure hydroxy-ketone was selectively 
reduced to obtain the corresponding ketone (1). The ketone was reacted with 
tosylhydrazide to obtain the tosylhydrazone ([). The tosyl-hydrazone was reacted with 
BuLi to give the final triene (!). There is spectral evidence of the formation of 1. ~and 1 
but characterization was not completed due to the small quantity of material. 
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CHAPTER V 
EXPERIMENTAL 
Diethyl malonate, and 1,4-dichloro-2-butene were obtained from Aldrich. Toluene 
and xylene were dried over anhydrous CaH2 and distilled. Trimethylsilyl chloride was 
purified by mixing it with a few drops of water to hydrolyze dichlorodimethylsilane 
impurity, followed by drying over anhydrous CaH2 and distillation. Petroleum ether, and 
ethyl acetate were distilled to remove the non-volatile impurity. The infrared spectra were 
taken on a Perkin-Elmer 1310 Infrared Spectrophotometer, and the NMR spectra were 
taken on a Varian VXR-300 Instrument. 1 H NMR were run in deuterochloroform unless 
otherwise stated. Flash-grade silica gel available from Baker was used for the column 
chromatography. 
Tetraethyl cis.cis-3.8-cyclodecadiene-1. 1.6.6-tetracarhoxylate C 4): A 2 L four-neck r.b. 
flask, fitted with a reflux condenser, two addition funnels, and a thermometer was charged 
with 100 g (0.80 mol) of 1,4-dichloro-2-butene. Then 300 mL ethanol was added to each 
addition funnel followed by 18.9 g (0.84 mol) of sodium spheres. After all the sodium 
reacted, slow addition of 63.9 g (0.40mol) of diethyl malonate was added to each addition 
funnel over 5 min. The solution in the addition funnels was kept hot by a heating tape. 
This solution was slowly added to 1,4-dichloro-2-butene in the flask over a period of 1 h. 
The temperature was maintained between 65 and 70 °C during the addition and for 
additional 5h of mechanical stirring. 
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The reaction mixture was cooled to room temperature and the solution was 
vacuum-filtered. The solvent was removed on a rotary evaporator, and the yellow oil was 
vacuum distilled at 65 °C and 0.3 mmHg. When the residue from the distillation was 
washed with heptane, white solid was left after washing which on recrystallization from 
chloroform/petroleum-ether gave 4.3 g (0.708 mmol, 2.6 %) of white crystals of the 
tetraester (.f). mp 160-162 °C; lit mp 160-161 °c. l8 1H-NMR: 8 5.3 (4H, m, vinylic 
CH), 4.25 (8H, q, OCH2), 2.79 (4H, t, CH2), 2.5 (4H, d, CH2), 1.28 (12H, t, CH3); 
13C-
NMR:8 171.3, 128.2, 62, 61.9, 57.2, 30.4, 14.6, 0.5; IR: 3100 (C=CH), 1700 (C=O), 
1650 (C=C) cm-1• 
Column chromatography of the tetraester washing was done using a silica gel 
column. Diethyl 2,7-dicarboethoxy-octa-4-enedioate Cffi) eluted with 4.5% ethyl acetate in 
petroleum ether while diethyl 2,7,7,12-tetracarboethoxy-trideca-4,9-dienedioate <11) eluted 
with 8% ethyl acetate in petroleum ether. Diethyl 2,7-dicarboethoxy-octa-4-enedioate (76): 
1H-NMR: 8 5.44 (2H, t, vinylic CH), 4.19 (8H, m, OCH2), 3.35 (2H, t, CH), 2.68 (4H, 
dd, CH2), 1.27 (12H, t, 4-CH3); 13C-NMR:8 168.9, 127.9, 61.4, 51.8, 26.6, 14.1, 14.0; 
IR: 3100 (C=CH), 1700 (C=O), 1650 (C=C) cm- 1• Diethyl 2,7,7,12-tetracarboethoxy-
trideca-4,9-dienedioate (77): 1H-NMR: 8 5.43 (4H, m, vinylic CH) 4.21 (12H, mixed q, 
OCH2), 3.33 (2H, t, CH), 2.65 (8H, q, CH2), 1.27 (18H, mixed t, CH2); 13C-NMR:8 
171.0, 169.0, 128.8, 126.0, 57.8, 51.9, 30.1, 26.8, 14.1; IR: 3100 (C=CH), 1700 (C=O), 
1650 (C=C) cm-1. 
Diethyl trans-3.8-cyclodecadiene-l.6-dicarboxylate (5): A 250 mL three neck r.b. flask 
fitted with a reflux condenser was charged with 85 mL of DMSO, 0.8 g NaCl and 0.6 mL 
of deionized water. The mixture was stirred and degassed at RT by vigorously bubbling 
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nitrogen gas through it for 20 min. The system was maintained under an atmosphere of 
nitrogen and 2.12 g (5.0 mmol) of the tetraester (.i) was added to it. The solution was 
refluxed under nitrogen for 24 h. The reaction mixture was cooled to RT and extracted 
with pentane (5x). The pentane extracts were combined and dried over anhydrous MgSO 4 
for 15 min. The solvent was removed on the rotary evaporater to obtain a yellow solid. 
This solid was washed with ice-cold methanol to remove DMSO and passed through silica 
gel, to afford 1.1 g (3.9 mmol, 78 %) of white solid. mp 41-42 °C; 1H-NMR: 8 5.45 (4H, 
m, vinylic CH), 4.21 (4H, 2 q, OCH2), 2.6 (2H, m, CH), 2.1 to 2.7 (8H, m, CH2), 1.32 
(6H, t, CH3); 13 C NMR: 8 175.3, 130.5, 129.9, 128.2, 127.6, 60.9, 42.8, 42.7, 27.1, 27.0, 
26.9, 14.8, 0.5; IR: 3010 (C=CH), 1720 (C=O), 1650 (C=C) cm-1• Mass Spectra: 280 
(16.0%), 235 (25.8%), 206(59.3%), 177 (5.6%), 161(30.8%),133 (100%), 105 (19.3%), 
91 (46.0%), 79 (38.9%), 67 (39.9%), 55 (12.0%). Rf (S) = 0.62. 
Bicyclof4.4.2ldodeca-11.12-bis(trimethylsilyloxy)-3.8.11-triene (83): A 50 mL three neck 
r.b. flask fitted with a reflux condenser and an addition funnel was charged with 0.1324 g 
(5.8 mmol) of sodium metal, and 0.2244 g (5.8 mmol) of potassium metal under nitrogen. 
The flask was heated until the metals melted and fused. The flask was cooled, and 10 mL 
of xylene was added to it. The solution was then vigorously stirred with a high speed 
stirrer to obtain a fine dispersion of the melted metal-alloy. The stirrer speed was reduced 
and 0.10 g (0.35 mmol) of the diester ~)and freshly distilled TMSCl (1 mL) was added to 
this suspension over 1 h at reflux temp., and the heating was continued for 6 h. The 
reaction mixture was then filtered in a dry bag under nitrogen. The solvent was removed 
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on a rotary evaporator to yield a yellow oil. 1H-NMR: o 5.4 (4H, m, vinylic CH), 2.8 
(2H, m, CH), 1.3-2.2 (8H, m, CH2). 0.25 (18H, S, OSi(CH3)3). 
The disilyl-ether (M) was mixed with 5 mL of methanol and stirred under a N1 
atmosphere at RT for 24 h. The solvent was removed on a rotary evaporator to obtain a 
yellow oil. IR: 3400 (0-H), 3010 (C=CH), 1700 (C=O), 1630 (C=C) cm·1• 
Bicyclo[ 4.4.2Jdodeca-11-hydroxy-3.8-diene-12-one (6): A 50 mL three neck r.b. flask 
fitted with a reflux condenser and an addition funnel was charged with 132 mg (5.8 
mmol) of sodium metal, and 224 mg (5.8 mmol) of potassium metal under nitrogen. The 
flask was heated until the metals melted and fused. The flask was cooled, and 10 mL of 
xylene was added to it. The solution was then vigorously stirred with a high speed stirrer 
to obtain a fine dispersion of the melted metal-alloy. The stirrer speed was reduced and 
0.10 g (0.35 mmol) of the diester CS) was added to this suspension over 1 h reflux temp., 
and the reflux was continued for 22 h. The reaction mixture was then filtered in a dry bag 
under nitrogen. The solvent was removed on a rotary evaporator to yield a yellow oil. 
Pure hydroxy-ketone (.6.) (3 mg, 0.015 mmol, 4%) was eluted with 20% ethyl acetate in 
petroleum ether. 1H-NMR: o 5.42 (4H, m, CH), 3.62 (3H, m, CH), 1.34-2.74 (8H, m, 
CH2); 
13C-NMR: 129.5, 127.2, 65.9, 40.2, 40.1, 29.7, 27.5, 25.5, 25.5, 0.01; The 
carbonyl carbon was seen in the impure .6. at 221 ppm before the chromatographic 
separation, however the quantitty of the pure hydroxy-ketone .6. was not enough to show 
carbonyl carbon in 13c. IR: 3400 (0-H), 3010 (C=C), 1700 (C=O), 1630 (C=C) cm·1. 
Mass spectra: 192, 178, 166, 153, 136, 121, 105, 91, 77, 67, 55. Mass calculated for 
C12H160 2 = 192.1150, found 192.1142. Rf (.6.) = 0.21. 
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Bicyclo[ 4.4.2ldodeca-3.8-diene-12-one (7): A three neck r. b. flask fitted with a reflux 
condenser was charged with 3 mg of the hydroxy-ketone ~) and 2 mL of toluene. It was 
mixed with 1.2 g of freshly prepared Zn/Hg and 2 mL of 4M-HC1. Zinc amalgam was 
prepared by stirring 1.2 g of mossy zinc, 0.12 g of HgC12, 1.5 mL of H20 and 0.06 mL of 
cone. HCI. The reaction mixture was refluxed for 2 112 h. The two layers were separated 
and the aqueous layer was extracted with 10 mL of methylene chloride. The organic layers 
were dried over anhydrous magnesium sulfate and the solvent was removed on the rotary 
evaporator to obtain 1 mg of yellow oil (0.0058 mmol, 37%). 1H-NMR: 8 5.48 (4H, m, 
vinylic CH), 4.25 (IH, m, CH), 3.72 (2H, m, CH2), 1.5-2.93 (9H, m, CH2 and CH). 
Bicyclof4.4.2ldodeca-3.8-diene-12-tosylhydrazone (8): To a 50 mL three neck r. b. flask 
was added 1 mg of the ketone, 2 mg of tosylhydrazide and 10 mL of absolute ethanol. The 
reaction mixture was refluxed for 6 h. The solvent was removed on the rotary evaporator 
to obtain< 1 mg solid. It was washed with 2 mL of chloroform. A 1H-NMR was 
recorded on a mixture of tosylhydrazone and tosylhydrazide. 1H-NMR: 8 7.85 (2H, m, 
ArH), 7.2 (2H, m, ArH), 5.44 (4H, m, vinylic CH), 2.47 (3H, s, CH3), 1.52-2.72 (9H, m, 
CH2 and CH). 
Bicyclof 4.4.2ldodeca-3.8.l 1-triene W: To a 25 mL three neck flask was added 1 mg of 
tosylhydrazone suspended in 5 mL of diglyme. An excess of 2.5M butyllithium in hexane 
was slowly added to this solution at -78 °c under a nitrogen atmosphere. The solution 
was stirred for 10 min and then allowed to warm to room temperature. The reaction 
mixture was maintained at 60 °c for next 6 h. The solution was cooled to room 
temperature, mixed with 2 mL of water and extracted with 50 mL of diethyl ether. The 
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solvent was removed on a rotary evaporator to obtain an oil which was separated by 
column chromatography on Florisil. Concentration of the early fraction with petroleum 
ether gave a hydrocarbon (<lmg) which appeared to be tliene 1by 1H-NMR. 1H-NMR: o 
5.7 (6H, m, vinylic H), 3.5-4.3 (6H, m, CH2 and CH), 1.85-2.7 (4H, m, CH2 ). 
Since some of the reactions used for the synthesis of the triene require special 
techniques, model reactions21 were run starting from dimethyl adipate. 
1.2-Disilyloxy-1-cyclohexene: A 250 mL three neck round-bottom flask fitted with a 
reflux condenser, and mechanical stirrer was charged with 1.9 g (80 mmoles) of sodium 
metal and 150 mL of toluene under nitrogen. The mixture was refluxed and vigorously 
stirred with a mechanical stirrer to obtain a fine dispersion of the sodium metal. To this 
mixture was slowly added a mixture of 3.05 g (20 mmoles) of dimethyl adipate and 9 g 
(80 moles) of TMSCl over a period of 1 h. The reaction mixture was maintained at reflux 
for 5 h. At the end of the reaction, the reaction mixture was filtered in the dry-box under an 
atmosphere of nitrogen. The solvent was removed on the rotary evaporator to obtain 4 g 
(12 mmol, 60 %) of yellow liquid. 1H-NMR: o 2.05 (2H, m, CH2), 1.6 (2H, m, CH2), 
1.25 (2H, m, CH2), 0.85 (2H, m, CH2). 0.2 (18H, s, OSi(CH3)). 
2-Hydroxycyclohexanone: A 250 mL three neck flask, fitted with a reflux condenser and 
an addition funnel was charged with 100 mL of reagent grade methanol. The methanol 
was degassed by bubbling nitrogen gas for a period of 30 min. The disilyl-ether was 
slowly added to methanol and the reaction mixture was stirred at a room temperature over 
a period of 26 h. The solvent was removed on a rotary evaporator to yield 1.3 g (11.8 
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mmol, 98 %) of dark brown liquid. 1H-NMR:8 3.8 (lH, s, CH2). 3.3 (lH, t, CH2), 1.2-
2.8 (5H, m, CH2 and OH), 1.0 (lH, m, CH2). IR: cm·1 3475 (OH), 1715 (C=O). 
Cyclohexanone: A 100 mL r.b. flask was charged with 1.78 g (27 mmol) of mossy zinc, 
2.3 mL water, and 0.1 mL of cone HCl. The solution was stirred, and 178 mg (0.65 
mmoles) of HgC12 was slowly added to the mixture. The solution was stirred for the next 
10 min. The solution was then decanted to remove the liquid part, and the zinc was mixed 
with 0.3 g (2.6 mmol) of hydroxy-ketone dissolved in 5 mL of toluene, and 15 mL of 4M-
HC1. The reaction mixture was refluxed for 2 h. The solution was cooled and extracted 
with diethyl ether (3x). The ether extracts were combined, and dried over anhydrous 
MgSO 4• The solvent was removed on a rotary evaporator to yield 0.2 g of yellow liquid. 
IR: cm·1 weak band at 3400 (OH), 1705 (C=O) 
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